Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3740084012 | Ethinylestradiol and norelgestromin only product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3740085013 | Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3740086014 | Ethinyl estradiol and norelgestromin only product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | a pour principe actif (attribut) | Ethinyl estradiol | true | Inferred relationship | Some | 1 | |
| Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | a pour principe actif (attribut) | Norelgestromin (substance) | true | Inferred relationship | Some | 2 | |
| Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme transdermique (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | est un(e) (attribut) | Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | est un(e) (attribut) | Product containing only ethinylestradiol and norelgestromin (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | Plays role | Contraceptive therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | est un(e) (attribut) | True | Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR